Mark E. Haskins
Affiliations: | Pathobiology | University of Pennsylvania, Philadelphia, PA, United States |
Google:
"Mark Haskins"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hinderer C, Bell P, Katz N, et al. (2017) Evaluation of intrathecal routes of administration for adeno-associated virus vectors in large animals. Human Gene Therapy |
| Hinderer C, Bell P, Louboutin JP, et al. (2016) Neonatal tolerance induction enables accurate evaluation of gene therapy for MPS I in a canine model. Molecular Genetics and Metabolism |
| Callan MB, Haskins ME, Wang P, et al. (2016) Successful Phenotype Improvement following Gene Therapy for Severe Hemophilia A in Privately Owned Dogs. Plos One. 11: e0151800 |
| Gurda BL, De Guilhem De Lataillade A, Bell P, et al. (2015) Evaluation of AAV-mediated gene therapy for central nervous system disease in canine mucopolysaccharidosis VII. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Hinderer C, Bell P, Louboutin JP, et al. (2015) Neonatal Systemic AAV Induces Tolerance to CNS Gene Therapy in MPS I Dogs and Nonhuman Primates. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Bradbury AM, Gurda BL, Casal ML, et al. (2015) A review of gene therapy in canine and feline models of lysosomal storage disorders. Human Gene Therapy. Clinical Development. 26: 27-37 |
| Hinderer C, Bell P, Gurda BL, et al. (2014) Liver-directed gene therapy corrects cardiovascular lesions in feline mucopolysaccharidosis type I. Proceedings of the National Academy of Sciences of the United States of America. 111: 14894-9 |
| Hinderer C, Bell P, Gurda BL, et al. (2014) Intrathecal gene therapy corrects CNS pathology in a feline model of mucopolysaccharidosis I. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 2018-27 |
| Bigg PW, Baldo G, Sleeper MM, et al. (2013) Pathogenesis of mitral valve disease in mucopolysaccharidosis VII dogs. Molecular Genetics and Metabolism. 110: 319-28 |
| Xing EM, Knox VW, O'Donnell PA, et al. (2013) The effect of neonatal gene therapy on skeletal manifestations in mucopolysaccharidosis VII dogs after a decade. Molecular Genetics and Metabolism. 109: 183-93 |